IOL Chemicals and Pharmaceuticals Ltd Stock Price Today (NSE: IOLCP)
Fundamental Score
IOL Chemicals and Pharmaceuticals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
IOL Chemicals and Pharmaceuticals Ltd share price today is ₹125.10, down 0.76% on NSE/BSE as of 17 June 2026. IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹2.64K (Cr). The 52-week high for IOLCP share price is ₹138.90 and the 52-week low is ₹67.19. At a P/E ratio of 22.72x, IOLCP is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 6.13% and a debt-to-equity ratio of 0.09.
IOL Chemicals and Pharmaceuticals Ltd Share Price Chart — NSE/BSE Historical Performance
IOL Chemicals and Pharmaceuticals Ltd share price chart: 42.53% return over the past month. 52-week high ₹138.90, 52-week low ₹67.19.
IOL Chemicals and Pharmaceuticals Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹124.98 | ₹132.00 | ₹123.97 | ₹131.42 | 26.96L (Cr) | |
| ₹130.00 | ₹135.03 | ₹121.55 | ₹125.87 | 39.05L (Cr) | |
| ₹131.90 | ₹132.92 | ₹128.02 | ₹128.98 | 28.25L (Cr) | |
| ₹131.40 | ₹131.40 | ₹131.40 | ₹131.40 | 0.00 (Cr) | |
| ₹136.65 | ₹137.59 | ₹130.00 | ₹131.40 | 45.42L (Cr) | |
| ₹124.95 | ₹138.90 | ₹124.94 | ₹136.06 | 191.47L (Cr) | |
| ₹119.21 | ₹126.00 | ₹119.21 | ₹124.00 | 64.02L (Cr) | |
| ₹121.05 | ₹124.40 | ₹118.21 | ₹118.73 | 58.29L (Cr) | |
| ₹118.81 | ₹126.72 | ₹114.47 | ₹121.17 | 176.47L (Cr) | |
| ₹109.00 | ₹121.40 | ₹107.01 | ₹119.54 | 210.91L (Cr) |
IOL Chemicals and Pharmaceuticals Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹130.00 | ₹135.03 | ₹121.55 | ₹131.42 | +1.09% | |
| ₹94.32 | ₹138.90 | ₹94.10 | ₹128.98 | +36.75% | |
| ₹75.50 | ₹97.79 | ₹73.81 | ₹94.32 | +24.93% | |
| ₹71.25 | ₹80.39 | ₹67.19 | ₹72.77 | +2.13% | |
| ₹73.00 | ₹83.40 | ₹70.20 | ₹73.05 | +0.07% | |
| ₹83.00 | ₹84.85 | ₹67.98 | ₹74.03 | -10.81% | |
| ₹90.23 | ₹91.34 | ₹79.07 | ₹82.26 | -8.83% | |
| ₹92.59 | ₹101.80 | ₹87.91 | ₹90.04 | -2.75% | |
| ₹103.10 | ₹108.38 | ₹92.00 | ₹92.53 | -10.25% | |
| ₹91.18 | ₹126.66 | ₹91.18 | ₹102.78 | +12.72% | |
| ₹103.00 | ₹103.34 | ₹88.64 | ₹90.74 | -11.90% | |
| ₹97.88 | ₹106.00 | ₹89.83 | ₹103.16 | +5.39% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
IOL Chemicals and Pharmaceuticals Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
IOL Chemicals and Pharmaceuticals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of IOLCP across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Attractive Valuation (P/E: 22.72 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (56.66%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.09)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (10.80x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹110.31 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (52.62%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (6.13%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.86%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Growth History (1.88% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-22.97% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-22.48% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Limited Institutional Interest (FII+DII: 2.30%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
IOL Chemicals and Pharmaceuticals Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare IOL Chemicals and Pharmaceuticals Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
42.1/100 | ₹125.10₹125 | ₹2638.81₹2638.81 | 22.72Average 22.7 Average | 6.13%Poor 6.13% Poor | 8.86%Poor 8.86% Poor | 0.09Excellent 0.1 Excellent | -22.48%Poor -22.48% Poor | 1.88%Average 1.88% Average | 0.89% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
IOL Chemicals and Pharmaceuticals Ltd PE Ratio History
Historical price-to-earnings ratio for IOLCP — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹3.44 | ₹82.26 | 23.9x |
| FY 2024 | ₹4.58 | ₹81.51 | 17.8x |
| FY 2023 | ₹4.74 | ₹92.66 | 19.5x |
| FY 2022 | ₹5.71 | ₹74.65 | 13.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
IOL Chemicals and Pharmaceuticals Ltd Dividend History
Annual cash dividends paid by IOLCP — dividend yield 0.89%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹23.48 Cr |
| FY 2024 | ₹29.35 Cr |
| FY 2023 | ₹23.50 Cr |
| FY 2022 | ₹35.22 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
IOL Chemicals and Pharmaceuticals Ltd Quarterly Performance
Latest quarterly metrics for IOLCP — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
7.95%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
56.66%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
1.88%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-22.48%
Compounded annual net profit growth over 5 years
IOL Chemicals and Pharmaceuticals Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for IOLCP — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
IOL Chemicals and Pharmaceuticals Ltd Financial Statements
Annual income statement, balance sheet and cash flow for IOL Chemicals and Pharmaceuticals Ltd (IOLCP) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for IOL Chemicals and Pharmaceuticals Ltd
About IOLCP (IOL Chemicals and Pharmaceuticals Ltd)
IOL Chemicals and Pharmaceuticals Ltd is a prominent player in the pharmaceutical and chemical manufacturing landscape, distinguished by its integrated operations and diverse produ...ct portfolio. The company stands as a reliable supplier, catering to a wide range of industries both domestically and internationally. Their commitment to quality and innovation is reflected in their advanced manufacturing facilities and stringent quality control processes, ensuring consistent product excellence and adherence to global standards. IOLCP prioritizes sustainable practices and environmental responsibility, striving to minimize its ecological footprint through efficient resource management and waste reduction initiatives. This dedication to both operational efficiency and environmental stewardship positions IOLCP as a trusted and forward-thinking partner in the chemical and pharmaceutical sectors. IOLCP's operational structure is strategically divided into two key segments: Chemicals and Pharmaceuticals. The Chemical segment manufactures a range of essential industrial chemicals, including ethyl acetate, renowned for its use in flexible packaging and food processing, and acetyl chloride, critical in pharmaceutical synthesis. Other key products like iso butyl benzene, mono chloro acetic acid, and acetic anhydride serve vital roles in textiles, paints, pesticides, and various chemical intermediates. The Pharmaceutical segment is dedicated to producing high-quality active pharmaceutical ingredients (APIs) that form the foundation for numerous life-saving medications. The company continually invests in research and development to expand its product offerings and meet the evolving needs of its diverse customer base. The company's global reach extends across numerous countries, solidifying its position as a significant exporter and contributing to India's reputation as a pharmaceutical and chemical hub. IOLCP’s success is built on a foundation of customer centricity, providing customized solutions and responsive support to meet specific client requirements. The company's adherence to ethical business practices and transparent operations has fostered long-term relationships with customers and stakeholders alike. IOLCP consistently aims to enhance its capabilities, optimize its supply chain, and strengthen its market presence, thereby driving sustainable growth and delivering value to its shareholders. Its enduring commitment to innovation and excellence ensures its continued success in the competitive pharmaceutical and chemical markets.
Company Details
Key Leadership
Corporate Events
IOLCP Share Price: Frequently Asked Questions
What is the current share price of IOL Chemicals and Pharmaceuticals Ltd?
IOL Chemicals and Pharmaceuticals Ltd (IOLCP) trades at ₹125.10 on NSE and BSE. Market cap ₹2.64K (Cr). Educational data only.
What is the P/E ratio of IOL Chemicals and Pharmaceuticals Ltd?
IOL Chemicals and Pharmaceuticals Ltd has a P/E of 22.72x vs industry average 31.77x.
What is the Bull Run score for IOL Chemicals and Pharmaceuticals Ltd?
IOL Chemicals and Pharmaceuticals Ltd has a Bull Run score of 42.1/100 based on 25+ financial parameters.
Does IOL Chemicals and Pharmaceuticals Ltd pay dividends?
IOL Chemicals and Pharmaceuticals Ltd has a dividend yield of 0.89%. Past dividends don't guarantee future payments.
What is the ROE of IOL Chemicals and Pharmaceuticals Ltd?
IOL Chemicals and Pharmaceuticals Ltd has ROE of 6.13%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of IOL Chemicals and Pharmaceuticals Ltd?
IOL Chemicals and Pharmaceuticals Ltd has debt-to-equity of 0.09.
Is IOL Chemicals and Pharmaceuticals Ltd a good investment?
Bull Run gives IOL Chemicals and Pharmaceuticals Ltd a score of 42.1/100. This is not investment advice — consult a SEBI-registered advisor.